Trademark Overview
On Friday, April 4, 2025, a trademark application was filed for ROIVANT with the United States Patent and Trademark Office. The USPTO has given the ROIVANT trademark a serial number of 99121352. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, April 4, 2025. This trademark is owned by Roivant Sciences GmbH. The ROIVANT trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for human use for the treatment of central nervous system, neurological, dementia, dermatological, metabolic, hematologic, infectious, auto-immune, immune deficiency, genetic, hepatological, cardiometabolic, urological, oncological, endocrine and endocrine-related, gynecological, ophthalmological, respiratory, cardiac, and pulmonary disorders, diseases and conditions